Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Berman

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
The Indian Journal of Medical Research|June 17, 2006
Visceral leishmaniasis in the New World & AfricaJonathan Berman
The American Journal of Tropical Medicine and Hygiene|December 17, 2014
Amphotericin B formulations and other drugs for visceral leishmaniasisJonathan Berman
Current Opinion in Infectious Diseases|September 23, 2003
Current treatment approaches to leishmaniasisJonathan Berman
Lancet (London, England)|September 20, 2005
Putting clinical trials into contextJonathan Berman
Current Infectious Disease Reports|December 22, 2004
Recent Developments in Leishmaniasis: Epidemiology, Diagnosis, and TreatmentJonathan Berman
Expert Opinion on Investigational Drugs|November 1, 2005
Clinical status of agents being developed for leishmaniasisJonathan Berman
Ergonomics|February 9, 2016
A life in errorJonathan Berman
The American Journal of Tropical Medicine and Hygiene|September 5, 2019
Liposomal Amphotericin B Treatment and the LeishmaniasesJonathan Berman
The American Journal of Tropical Medicine and Hygiene|May 2, 2009
ABLE: a new and improved amphotericin B for visceral leishmaniasis?Jonathan Berman
Expert Opinion on Pharmacotherapy|July 15, 2005
Miltefosine to treat leishmaniasisJonathan Berman
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
The Indian Journal of Medical Research|June 17, 2006
Visceral leishmaniasis in the New World & AfricaJonathan Berman
The American Journal of Tropical Medicine and Hygiene|December 17, 2014
Amphotericin B formulations and other drugs for visceral leishmaniasisJonathan Berman
Current Opinion in Infectious Diseases|September 23, 2003
Current treatment approaches to leishmaniasisJonathan Berman
Lancet (London, England)|September 20, 2005
Putting clinical trials into contextJonathan Berman
Current Infectious Disease Reports|December 22, 2004
Recent Developments in Leishmaniasis: Epidemiology, Diagnosis, and TreatmentJonathan Berman
Expert Opinion on Investigational Drugs|November 1, 2005
Clinical status of agents being developed for leishmaniasisJonathan Berman
Ergonomics|February 9, 2016
A life in errorJonathan Berman
The American Journal of Tropical Medicine and Hygiene|September 5, 2019
Liposomal Amphotericin B Treatment and the LeishmaniasesJonathan Berman
The American Journal of Tropical Medicine and Hygiene|May 2, 2009
ABLE: a new and improved amphotericin B for visceral leishmaniasis?Jonathan Berman
Expert Opinion on Pharmacotherapy|July 15, 2005
Miltefosine to treat leishmaniasisJonathan Berman
Pageof 6